This is a Illumina news story, published by Yahoo Finance.
For more Illumina news, you can click here:
more Illumina newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Core Illumina revenue. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Core Illumina news, biotechnology companies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
machine maker IlluminaReuters
•82% Informative
Illumina has seen sluggish demand for its tools and services from key markets such as China and cautious spending from its customers such as biotechnology companies.
Core Illumina revenue to decline 2% to 3% , compared to the previous year .
Analysts expect full-year adjusted profit of $ 3.91 per share for the whole company.
VR Score
93
Informative language
99
Neutral language
72
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links